![Stephen Haworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Haworth
Technik-/Wissenschafts-/F&E-Leiter bei
XORTX THERAPEUTICS INC.
Vermögen: - $ am 31.05.2026
Profil
Stephen Haworth is Chief Medical Officer at XORTX Therapeutics, Inc. since 2021.
Former positions include Executive Director-Medical at CorMedix, Inc. from 2017 to 2018, Chief Medical Officer & Vice President at Elusys Therapeutics, Inc. from 2012 to 2013, and Vice President at VaxInnate Corp.
from 2015 to 2016.
Education includes undergraduate studies at University College London and a doctorate from UCL Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Stephen Haworth
| Unternehmen | Position | Beginn |
|---|---|---|
| XORTX THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 |
Ehemalige bekannte Positionen von Stephen Haworth
| Unternehmen | Position | Ende |
|---|---|---|
| CORMEDIX INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2013 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Corporate Officer/Principal | 01.04.2016 |
Ausbildung von Stephen Haworth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
UCL Medical School
 UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
